Compositions and methods of use for binding molecules to Dickkopf-1 or Dickkopf-4 or both

Details for Australian Patent Application No. 2010245833 (hide)

Owner Novartis AG

Inventors Braendle, Edgar; Rae, Patricia; Rangwala, Shamina M.; Stover, David Raymond; Taylor, Ann

Agent Davies Collison Cave

Pub. Number AU-A-2010245833

PCT Pub. Number WO2010/129752

Priority 61/176,317 07.05.09 US

Filing date 6 May 2010

Wipo publication date 11 November 2010

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/129752 Priority application(s): WO2010/129752

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010245834-Medicinal inhalation device

2010245823-Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same